Last reviewed · How we verify
HCP1007
At a glance
| Generic name | HCP1007 |
|---|---|
| Sponsor | Hanmi Pharmaceutical Company Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007 (PHASE1)
- Clinical Trial to Evaluate the Effect on the Pharmacokinetic Characteristics of HCP1007 Capsule (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HCP1007 CI brief — competitive landscape report
- HCP1007 updates RSS · CI watch RSS
- Hanmi Pharmaceutical Company Limited portfolio CI